A new study has revealed that a traditional Chinese herbal remedy can be as effective as methotrexate for treating rheumatoid arthritis.
Scientists have revealed that if the herbal medicine, which is used to relieve joint pain and inflammation, is combined with methotrexate then the treatment can be all the more effective.
The researchers wanted to find out which of these approaches would sufficiently alleviate symptoms to reach an ACR 50 response, which indicates a 50 percent improvement in the number of tender or swollen joints and other criteria including pain, disability, and the doctor's assessment of disease severity.
The scientists found that the proportion of patients achieving ACR 50 was almost 46.5 percent in those treated with methotrexate alone, while 55 sucess in those treated with TwHF alone and just under 77 percent in those treated with both.
The study was published online in the Annals of the Rheumatic Diseases.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
